Nurix Therapeutics (NASDAQ:NRIX) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Several other research analysts have also issued reports on NRIX. Leerink Partnrs raised Nurix Therapeutics to a “hold” rating in a research report on Monday, March 17th. Wells […]
Wall Street Zen upgraded shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Several other research analysts have also issued reports on NRIX. Leerink Partnrs raised Nurix Therapeutics to a “hold” rating in a research report on Monday, March 17th. Wells […]
